+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

From
From
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMCIVREE (Setmelanotide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
From
From
Hypothalamic Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypothalamic Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Obesity Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Obesity Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Global Obesity Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Obesity Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
From
From
Global Anti-obesity Drugs Market 2023-2027 - Product Thumbnail Image

Global Anti-obesity Drugs Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
From
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more